Valuation: GENFIT

Market Cap 588M 679M 556M 504M 945M 65.07B 952M 6.63B 2.55B 33B 2.55B 2.49B 105B P/E 2026 *
30.3x
P/E 2027 * 67.1x
Enterprise Value 537M 620M 508M 460M 863M 59.42B 869M 6.06B 2.33B 30.13B 2.33B 2.28B 96.12B EV / Sales 2026 *
5.36x
EV / Sales 2027 * 4.1x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-5.77%
1 week-13.40%
Current month-16.83%
1 month-9.68%
3 months+27.00%
6 months+38.52%
Current year+123.36%
1 week 11.66
Extreme 11.66
14.5
1 month 11.66
Extreme 11.66
14.98
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 15/09/2019
Director of Finance/CFO 52 21/04/2021
Chief Tech/Sci/R&D Officer - 26/11/2025
Director TitleAgeSince
Chairman 70 15/06/2017
Director/Board Member 54 14/09/1999
Director/Board Member 58 15/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
05/03/26 Exercice

Chief Operating Officer

11,250 0.0225%
05/03/26 Exercice

Chief Operating Officer

7,083 0.0142%
05/03/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-5.77%-13.40%+226.49%+217.41% 720M
+0.56%-4.17%-1.90%+9.79% 45.63B
-0.12%-2.46%+340.09%+529.37% 43.96B
+1.51%+0.71%+44.04%+26.63% 43.73B
-2.07%-3.28%+6.83%+74.56% 40.23B
-0.73%-4.72%+8.55%+37.89% 31.86B
-9.49%-11.38% - - 17.4B
+4.21%+4.94%+26.46%+121.58% 16.62B
+1.83%+2.63%+15.14%+33.31% 14.46B
-0.08%-5.41%+78.48%+31.34% 13.04B
Average -0.20%-2.44%+82.69%+120.21% 26.76B
Weighted average by Cap. +0.18%-2.11%+76.65%+128.51%

Financials

2026 *2027 *
Net sales 100M 116M 94.75M 85.87M 161M 11.09B 162M 1.13B 435M 5.63B 435M 425M 17.94B 127M 147M 120M 109M 204M 14.05B 206M 1.43B 551M 7.12B 550M 538M 22.73B
Net income 22.88M 26.4M 21.62M 19.59M 36.75M 2.53B 37.03M 258M 99.24M 1.28B 99.14M 96.96M 4.09B 800K 923K 756K 685K 1.29M 88.49M 1.29M 9.02M 3.47M 44.87M 3.47M 3.39M 143M
Net Debt -51.11M -58.98M -48.29M -43.76M -82.09M -5.65B -82.71M -576M -222M -2.87B -221M -217M -9.14B -67.56M -77.97M -63.83M -57.85M -109M -7.47B -109M -762M -293M -3.79B -293M -286M -12.09B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
15/09/26 €11.76 -5.77% 367,572
14/09/26 €12.48 -4.15% 281,734
11/09/26 €13.02 -4.96% 424,279
10/09/26 €13.70 +11.38% 475,388
09/09/26 €12.30 -6.11% 255,773
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.76EUR
Average target price
18.10EUR
Spread / Average Target
+53.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!